首页> 外文期刊>Journal of orthopaedic research >Development of a bovine decellularized extracellular matrix-biomaterial for nucleus pulposus regeneration
【24h】

Development of a bovine decellularized extracellular matrix-biomaterial for nucleus pulposus regeneration

机译:牛脱细胞核外基质再生生物材料的开发

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Painful intervertebral disc (IVD) degeneration is a common cause for spinal surgery. There is a clinical need to develop injectable biomaterials capable of promoting IVD regeneration, yet many available biomaterials do not mimic the native extracellular matrix (ECM) or promote matrix production. This study aimed to develop a decellularized injectable bovine ECM material that maintains structural and compositional features of native tissue and promotes nucleus pulposus (NP) cell (NPC) and mesenchymal stem cell (MSC) adaption. Injectable decellularized ECM constructs were created using 3 NP tissue decellularization methods (con.A: sodium deoxycholate, con.B: sodium deoxycholate & sodium dodecyl sulfate, con.C: sodium deoxycholate, sodium dodecyl sulfate & TritonX-100) and evaluated for protein, microstructure, and for cell adaptation in 21 day human NPC and MSC culture experiments. Con.A was most efficient at DNA depletion, preserved best collagen microstructure and content, and maintained the highest glycosaminoglycan (GAG) content. NPCs in decellularized constructs of con.A&B demonstrated newly synthesized GAG production, which was apparent from halos of GAG staining surrounding seeded NPCs. Con.A also promoted MSC adaption with high cell viability and ECM production. The injectable decellularized NP biomaterial that used sodium deoxycholate without additional decellularization steps maintained native NP tissue structure and composition closest to natural ECM and promoted cellular adaptation of NP cells and MSCs. This natural decellularized biomaterial warrants further investigation for its potential as an injectable cell seeded supplement to augment NP replacement biomaterials and deliver NPCs or MSCs. (c) 2015 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 34:876-888, 2016.
机译:疼痛性椎间盘退变是脊柱外科手术的常见原因。临床上需要开发能够促进IVD再生的可注射生物材料,但是许多可用的生物材料不能模仿天然细胞外基质(ECM)或促进基质产生。这项研究旨在开发一种脱细胞的可注射牛ECM材料,该材料可保持天然组织的结构和组成特征,并促进髓核(NP)细胞(NPC)和间充质干细胞(MSC)适应。使用3种NP组织脱细胞方法创建可注射的脱细胞ECM构建体(A组:脱氧胆酸钠,B组:脱氧胆酸钠和十二烷基硫酸钠,C组:脱氧胆酸钠,十二烷基硫酸钠和TritonX-100)并评估蛋白质,微结构以及在21天人类NPC和MSC培养实验中的细胞适应性。 Con.A在去除DNA方面最有效,保留了最佳的胶原微结构和含量,并保持了最高的糖胺聚糖(GAG)含量。 con.A&B脱细胞构建物中的NPC证明了新合成的GAG产生,这可从种子NPC周围的GAG染色晕染看出。 Con.A还以高细胞活力和ECM产生促进了MSC适应。使用脱氧胆酸钠而不需额外脱细胞步骤的可注射脱细胞NP生物材料,可维持最接近天然ECM的天然NP组织结构和组成,并促进NP细胞和MSC的细胞适应性。这种天然的脱细胞生物材料需要进一步研究其作为可注射细胞接种的补充剂的潜力,以增强NP替代生物材料并传递NPC或MSC。 (c)2015骨科研究学会。由Wiley Periodicals,Inc.出版J Orthop Res 34:876-888,2016。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号